arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Praxis Precision Medicines, Inc.

PRAX

$360.80 ▼ -8.61 (-2.33%) at close

29 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Praxis Precision Medicines, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $10.4B

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -5.9% ↗

FCF / Share $-2.98

Trailing P/E —

Price / Book 7.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

29-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-92.56M

↓ -33.6% —

FCF / Share Free cash flow per share

$-2.98

↓ -18.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	—	N/M	N/M	N/M	N/M	1349.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+16764%)	-35.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-543%)	-54.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-779%)	-36.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-561%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	2.7% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-17.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-22.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-90.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-15.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-53.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	76.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	73.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	97.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	81.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	53.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-230.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	4.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	N/M	91.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	89.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-33.6% Weak ↑ Weak Improving Year-over-year change in net income	-51.5% Weak ↑ Weak Improving Year-over-year change in net income	-75.2% Weak ↑ Weak Improving Year-over-year change in net income	-75.2% Weak ↓ Weak Declining Year-over-year change in net income	-75.2% Weak ↓ Weak Declining Year-over-year change in net income	-118.3% Weak ↓ Weak Declining Year-over-year change in net income	-5.6% Weak ↓ Weak Declining Year-over-year change in net income	-5.6% Weak ↓ Weak Declining Year-over-year change in net income	-5.6% Weak ↓ Weak Declining Year-over-year change in net income	34.7% Excellent ↓ Excellent Declining Year-over-year change in net income	45.5% Excellent ↑ Excellent Improving Year-over-year change in net income	45.5% Excellent ↑ Excellent Improving Year-over-year change in net income	45.5% Excellent ↑ Excellent Improving Year-over-year change in net income	29.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-151.0% Weak ↓ Weak Declining Year-over-year change in net income	-88.8% Weak ↑ Weak Improving Year-over-year change in net income	-151.0% Weak ↑ Weak Improving Year-over-year change in net income	-127.9% Weak ↑ Weak Improving Year-over-year change in net income	-228.6% Weak → Weak Stable Year-over-year change in net income	-214.7% Weak ↓ Weak Declining Year-over-year change in net income	-228.6% Weak ↓ Weak Declining Year-over-year change in net income	-247.9% Weak Weak Year-over-year change in net income	21.5% Good Good Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-18.6% Weak Weak Year-over-year change in free cash flow	—	—	—	-67.8% Weak Weak Year-over-year change in free cash flow	—	—	—	83.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	48.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	-0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
FCF / Net Income (x)	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.67x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.35x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-23.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-46.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	20.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	13.2% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	11.1% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	9.3% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	7.3% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	11.7% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-7.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-23.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-28.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-15.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-6.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-10.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-20.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-17.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-15.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-13.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-10.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-9.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-17.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-38.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-357%)	-43.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-388%)	-35.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-336%)	-58.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-487%)	-39.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-361%)	-65.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-536%)	-49.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-430%)	-36.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-340%)	-19.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-232%)	-9.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-10.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-10.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	20.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+39%)	6.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	11.1% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-26%)	9.2% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	9.1% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	14.7% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-536.33M	$-357.33M	$-149.53M	$-157.41M	$-165.57M	$-215.37M	$-168.65M	$-145.14M	$-151.98M	$-81.30M	$-101.08M	$-124.30M	$-80.84M	$-61.62M	$-62.44M	$-56.04M	$-77.85M	$-138.70M	$-165.68M	$-175.88M	$-131.15M	$-296.61M	$-114.77M	$-19.75M	$-6.25M	$-44.81M	$-4.32M	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	—	—	$0.00	$0.00	$0.00	—	$0.02	$0.02	$0.03	—	$0.05	$0.17	$0.19	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-3.20	$-3.51	$-3.36	$-3.31	$-3.29	$-3.00	$-2.75	$-1.74	$-2.84	$-1.96	$-2.70	$-7.35	$-10.64	$-65.86	$-14.39	$-19.79	$-22.64	$-19.94	$-14.99	$-13.19	—	$279.91	$-181.41	$-124.14	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.98	—	$-2.96	$-2.55	$-2.52	—	—	—	$-1.50	—	—	—	$-9.27	—	—	$-18.87	$-17.94	—	—	—	—	—	$-124.93	$-90.77	—	—	—	—	—
Book Value per Share (USD)	$50.61	$34.85	$16.23	$19.21	$21.59	$22.93	$21.52	$23.60	$17.32	—	$10.12	$12.32	$16.68	$31.94	$33.64	$45.72	$62.93	$97.94	$99.07	$111.97	$103.07	$-48.29	$-1.11K	$-950.07	—	$-748.83	—	—	—
Tangible Book Value per Share (USD)	$50.61	$34.85	$16.23	$19.21	$21.59	$22.93	$21.52	$23.60	$17.32	—	$10.12	$12.32	$16.68	$31.94	$33.64	$45.72	$62.93	$97.94	$99.07	$111.97	$103.07	$-48.29	$-1.11K	$-950.07	—	$-748.83	—	—	—
Basic Weighted Avg Shares (shares)	28.88M	—	21.98M	21.47M	21.06M	—	18.88M	18.82M	13.90M	—	9.04M	4.65M	3.54M	—	3.05M	3.04M	3.03M	—	2.98M	2.77M	—	—	111,116	109,554	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$747.53M	$551.14M	$220.96M	$257.97M	$294.05M	$366.82M	$327.19M	$336.10M	$193.01M	—	$86.53M	$105.40M	$64.49M	$76.50M	$103.33M	—	$189.25M	$248.97M	$294.58M	$332.65M	$264.83M	$286.61M	—	—	—	$38.68M	—	—	—
Total Equity (USD)	$1.41B	$878.14M	$343.50M	$404.22M	$439.21M	$445.45M	$382.67M	$419.10M	$229.68M	$69.67M	$86.76M	$105.62M	$64.47M	$105.16M	$105.16M	$138.87M	$191.02M	$295.92M	$295.92M	$333.77M	$265.51M	$-123.26M	$-123.26M	$-104.08M	$-90.76M	$-81.01M	$-72.06M	$-60.46M	$-41.04M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$0.00	$0.00	$0.00	$7.46M	$302.00K	$357.00K	$431.00K	$515.00K	$468.00K	$781.00K	$683.00K	$0.00	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$39.00K	$28.00K	$19.00K	$46.00K	$47.00K	$47.00K	—	—	$112.00K	$111.00K	—	—	$106.00K	$105.00K	—	$119.00K	$93.00K	$93.00K	—	—	$23.00K	$20.00K	$10.00K	$10.00K	$10.00K	$10.00K	—	—	—
Net Income, GAAP (USD)	$-92.56M	$-88.91M	$-69.30M	$-69.30M	$-69.30M	$-58.68M	$-39.55M	$-39.55M	$-39.55M	$-26.88M	$-37.45M	$-37.45M	$-37.45M	$-41.17M	$-68.72M	$-68.72M	$-68.72M	$-58.58M	$-27.37M	$-36.40M	$-27.37M	$-25.71M	$-8.33M	$-11.57M	$-8.33M	$-7.39M	$-10.61M	—	—
Operating Cash Flow (USD)	$-86.15M	$-76.33M	$-65.06M	$-54.68M	$-53.01M	$-56.12M	—	—	$-20.86M	$-23.86M	—	—	$-32.85M	$-28.81M	—	$-57.21M	$-54.11M	$-44.86M	—	—	$-25.72M	$-20.23M	$-13.88M	$-9.94M	$-8.57M	$-9.95M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 29 quarters

Praxis Precision Medicines, Inc.

Analytical Summary

29-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PRAX with peers